1. Home
  2. /
  3. Author: nferreyros
nferreyros

About nferreyros

This author has not yet filled in any details.
So far nferreyros has created 6 blog entries.

Search Results


The Myth of Perverse Physician Incentives: Examining Research and Accusations in the Medicare Part B ASP Reimbursement System for Oncology

A frequent accusation aimed at physicians who prescribe and administer medications within the Medicare Part B system is that they are motivated by a perverse incentive of higher reimbursement to prescribe expensive drugs. For oncologists, who utilize potentially life-saving, but increasingly very expensive drugs in treating some of the nation’s sickest patients, this is a

2018-12-31T14:03:15+00:00 December 31, 2018|Publications|Comments Off on The Myth of Perverse Physician Incentives: Examining Research and Accusations in the Medicare Part B ASP Reimbursement System for Oncology

COA Formal Comments on International Pricing Index Model for Medicare Part B Drugs

On behalf of the Board of Directors of the Community Oncology Alliance (COA), we are submitting this comment letter regarding the Medicare Program; International Pricing Index Model for Medicare Part B Drugs (CMS-5528-ANPRM) (the “IPI Model”). As you know, COA is an organization that is dedicated to advocating for the complex care and access needs

2018-12-31T13:40:36+00:00 December 31, 2018|Member News, Position Statements & Comment Letters|Comments Off on COA Formal Comments on International Pricing Index Model for Medicare Part B Drugs

COA Comments Objecting to CVS-Aetna Merger

Peter Mucchetti, Esq. Peter.J.Mucchetti@usdoj.gov Antitrust.atr@usdoj.gov Chief, Healthcare and Consumer Products Section, Antitrust Division, Department of Justice 450 Fifth Street NW, Suite 4100 Washington, DC 20530 RE: United States of America v. CVS Health Corporation and Aetna Inc. Dkt. No.: 1:18-cv-02340 Dear Mr. Mucchetti: The Community Oncology Alliance (“COA”) submits this letter on behalf of

2018-12-20T11:06:28+00:00 December 16, 2018|Position Statements & Comment Letters, Publications|Comments Off on COA Comments Objecting to CVS-Aetna Merger

Cancer Center of Middle Georgia Launches Local Chapter of National Advocacy Organization

New CPAN Chapter Gives Cancer Patients, Survivors A Forum to Speak Out for Access to Local Cancer Care The Cancer Center of Middle Georgia (CCMG) at the practice’s offices at 2400 Bellevue Road, Suite #26, in Dublin, launched a new local chapter of the Community Oncology Alliance Patient Advocacy Network (CPAN), which will advocate for

2019-01-11T07:02:57+00:00 December 3, 2018|Latest News previous year, Press Releases & Statements, test bk|Comments Off on Cancer Center of Middle Georgia Launches Local Chapter of National Advocacy Organization

COA needs your support for 2019!

We are about to enter a critical period for community oncology. Far-reaching Medicare policies are under consideration in Washington that have the potential to completely transform your practice and, quite possibly, ability to survive. From the way you and your practice are reimbursed; to how you acquire and deliver complex cancer drugs; to your ability

2018-11-29T17:45:40+00:00 November 29, 2018|Member News|Comments Off on COA needs your support for 2019!

COA Statement on Trump Administration’s Part B Payment Model Proposal

Oncologists Express Concerns About Patient Access to Cancer Treatment With Potential Introduction of Middlemen to Medicare Part B Today the Community Oncology Alliance (COA) released the following statement regarding the Advanced Notice of Proposed Rulemaking (ANPRM) for an International Pricing Index (IPI) Model unveiled by President Trump and United States Secretary of Health and Human Services (HHS)

2019-01-11T07:08:36+00:00 October 25, 2018|Latest News previous year, Press Releases & Statements, test bk|Comments Off on COA Statement on Trump Administration’s Part B Payment Model Proposal